JPM vs OPBK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
OPBK presents a compelling deep-value opportunity, trading significantly below its Graham Number ($24.34) and Intrinsic Value ($50.74). While the Piotroski F-Score of 4/9 indicates only stable financial health and technical trends are currently bearish, the company's fundamental growth is robust with YoY earnings growth of 42.70%. The stock is trading at a discount to book value (P/B 0.92) and a low P/E of 8.21, suggesting significant margin of safety. The bullish outlook is driven by strong profitability and valuation, despite weak insider sentiment.
Compare Another Pair
Related Comparisons
JPM vs OPBK: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and OP Bancorp (OPBK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.